134 related articles for article (PubMed ID: 16911781)
1. Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane.
Godeiro KD; Frota AC; Antecka E; Odashiro AN; Maloney S; Fernandes B; Burnier MN
J Carcinog; 2006 Aug; 5():21. PubMed ID: 16911781
[TBL] [Abstract][Full Text] [Related]
2. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.
Chang SS; Reuter VE; Heston WD; Gaudin PB
Urology; 2001 Apr; 57(4):801-5. PubMed ID: 11306418
[TBL] [Abstract][Full Text] [Related]
4. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB
Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975
[TBL] [Abstract][Full Text] [Related]
5. Prostate-Specific Membrane Antigen (PSMA) Expression in The Neovasculature of High Grade Gliomas (Histopathological and Immunohistochemical Study).
Abdel Maguid MS; Saad El Dine MG; Gabal SM; Abou Fandoud SM
Asian Pac J Cancer Prev; 2023 May; 24(5):1797-1808. PubMed ID: 37247303
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific membrane antigen expression in normal and malignant human tissues.
Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C
Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541
[TBL] [Abstract][Full Text] [Related]
8. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
[TBL] [Abstract][Full Text] [Related]
11. Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy.
Ciulla TA; Danis RP; Criswell M; Pratt LM
Expert Opin Investig Drugs; 1999 Dec; 8(12):2173-2182. PubMed ID: 11139846
[TBL] [Abstract][Full Text] [Related]
12. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
[TBL] [Abstract][Full Text] [Related]
13. The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents.
Adatia FA; Luong M; Munro M; Tufail A
Surv Ophthalmol; 2015; 60(3):204-15. PubMed ID: 25890624
[TBL] [Abstract][Full Text] [Related]
14. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.
Wright GL; Haley C; Beckett ML; Schellhammer PF
Urol Oncol; 1995; 1(1):18-28. PubMed ID: 21224086
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.
Chang SS; Reuter VE; Heston WD; Gaudin PB
Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343
[TBL] [Abstract][Full Text] [Related]
16. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravitreal connective tissue growth factor neutralizing antibody on choroidal neovascular membrane-associated subretinal fibrosis.
Daftarian N; Rohani S; Kanavi MR; Suri F; Mirrahimi M; Hafezi-Moghadam A; Soheili ZS; Ahmadieh H
Exp Eye Res; 2019 Jul; 184():286-295. PubMed ID: 31029789
[TBL] [Abstract][Full Text] [Related]
18. Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes.
Nicolò M; Birò A; Cardillo-Piccolino F; Castellani P; Giovannini A; Mariotti C; Zingirian M; Neri D; Zardi L
Am J Ophthalmol; 2003 Jan; 135(1):7-13. PubMed ID: 12504690
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
[TBL] [Abstract][Full Text] [Related]
20. Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors.
Milowsky MI; Nanus DM; Kostakoglu L; Sheehan CE; Vallabhajosula S; Goldsmith SJ; Ross JS; Bander NH
J Clin Oncol; 2007 Feb; 25(5):540-7. PubMed ID: 17290063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]